SCHEMBL15912872

SCHEMBL15912872

Cc1ccc(B(O)O)c(F)c1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.38
FEN1 P39748 2/20 0.38
PREP P48147 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29950952 0.84 ALOX5AP (0.36) ALOX5APFEN1
SCHEMBL15912887 0.84 FEN1 (0.54) ALOX5APFEN1
SCHEMBL3440600 0.79 ALOX5AP (0.33) ALOX5APFEN1
SCHEMBL15912738 0.78 FEN1 (0.39) ALOX5APFEN1
SCHEMBL15912735 0.77 FEN1 (0.38) ALOX5APFEN1
SCHEMBL2555302 0.74 DRD2 (0.33) ALOX5APFEN1PREP
SCHEMBL21751366 0.74 ENPP2 (0.38) ALOX5APFEN1
SCHEMBL19975327 0.73 PREP (0.35) ALOX5APFEN1PREP
SCHEMBL3839000 0.73 TUBB1 (0.38)
SCHEMBL12577662 0.72 CA12 (0.44) PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951169-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-08-28 EP disclosed
US-9926333-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2018-03-27 US disclosed
US-20170327514-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-11-16 US disclosed
US-9732093-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-15 US disclosed
US-20150368270-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-24 US disclosed
US-20150252008-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-10 US disclosed
US-9073876-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-07 US disclosed
US-20140221310-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327514-A1 FLAP MODULATORS FEN1, PGF, TBXA2R ALOX5AP 70/4885FEN1 1/4885PREP 2771/4885
US-20140221310-A1 FLAP MODULATORS FEN1, PGF, PTGIS ALOX5AP 61/4885FEN1 1/4885PREP 3343/4885
US-20150368270-A1 FLAP MODULATORS FEN1, PGF, TBXA2R ALOX5AP 70/4885FEN1 1/4885PREP 2771/4885
US-20150252008-A1 FLAP MODULATORS FEN1, PGF, PTGIS ALOX5AP 61/4885FEN1 1/4885PREP 3343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.